We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.36B
AUM Growth
-$521M
Cap. Flow
-$561M
Cap. Flow %
-16.68%
Top 10 Hldgs %
31.32%
Holding
2,193
New
694
Increased
377
Reduced
430
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPOF
926
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$505K 0.02%
+49,500
New +$510K
CAT icon
927
PUT
Caterpillar
CAT
$387B
$504K 0.02%
2,800
+1,000
+56% +$231K
AXP icon
928
PUT
American Express
AXP
$230B
$503K 0.02%
3,600
TRTX
929
TPG RE Finance Trust
TRTX
$618M
$503K 0.02%
36,852
-7,546
-17% -$96.7K
TPL icon
930
Texas Pacific Land
TPL
$23.5B
$502K 0.01%
2,826
+1,206
+74% +$210K
FCX icon
931
CALL
Freeport-McMoran
FCX
$97.5B
$501K 0.01%
13,500
-99,000
-88% -$3.86M
BTWN
932
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$501K 0.01%
+49,507
New +$514K
MSAC
933
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$501K 0.01%
+51,900
New +$507K
JPM icon
934
PUT
JPMorgan Chase
JPM
$950B
$500K 0.01%
3,800
+800
+27% +$126K
KRC icon
935
Kilroy Realty
KRC
$4.42B
$500K 0.01%
+7,114
New +$493K
KTOS icon
936
Kratos Defense & Security Solutions
KTOS
$11.4B
$500K 0.01%
+17,547
New +$464K
NAUT icon
937
Nautilus Biotechnolgy
NAUT
$115M
$500K 0.01%
+49,500
New +$536K
SPHB icon
938
Invesco S&P 500 High Beta ETF
SPHB
$933M
$500K 0.01%
+6,617
New +$491K
BP icon
939
BP
BP
$107B
$499K 0.01%
18,875
-18,811
-50% -$493K
HROW icon
940
Harrow
HROW
$1.51B
$499K 0.01%
53,718
+20,869
+64% +$178K
NIR
941
DELISTED
Near Intelligence, Inc. Common Stock
NIR
$499K 0.01%
+51,099
New +$499K
RAD
942
DELISTED
Rite Aid Corporation
RAD
$499K 0.01%
+30,597
New +$586K
ICLN icon
943
PUT
iShares Global Clean Energy ETF
ICLN
$2.1B
$497K 0.01%
+21,200
New +$484K
UI icon
944
Ubiquiti
UI
$34.3B
$497K 0.01%
1,591
-181
-10% -$53K
VAQC
945
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$497K 0.01%
50,000
JYAC
946
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$497K 0.01%
+50,012
New +$497K
MOS icon
947
The Mosaic Company
MOS
$7.33B
$496K 0.01%
15,559
+684
+5% +$23.2K
TCVA
948
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$496K 0.01%
+50,000
New +$507K
ACB
949
CALL
Aurora Cannabis
ACB
$185M
$495K 0.01%
4,410
-810
-16% -$70.2K
SST icon
950
System1
SST
$17.5M
$495K 0.01%
+5,000
New +$497K

Similar funds

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

  • Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
  • Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
  • Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
  • Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
  • Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
  • Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.